| dc.contributor.author | Lagrange, Sophie | - |
| dc.contributor.author | Roubert, Christine | - |
| dc.contributor.author | Zhang, Jidong | - |
| dc.date.accessioned | 2024-01-08T09:19:03Z | |
| dc.date.available | 2024-01-08T09:19:03Z | |
| dc.date.issued | 2023 | |
| dc.identifier.citation | Lagrange, Sophie ; Roubert, Christine ; Zhang, Jidong ; Les séquanamycines, puissants macrolides oraux anti-tuberculeux dérivés d’un produit naturel, Med Sci (Paris), Vol. 39, N° 8-9 ; p. 599-602 ; DOI : 10.1051/medsci/2023091 | |
| dc.identifier.issn | 1958-5381 | |
| dc.identifier.uri | http://hdl.handle.net/10608/14563 | |
| dc.language.iso | fr | |
| dc.publisher | EDP Sciences | |
| dc.relation.ispartof | Nouvelles | |
| dc.rights | Article en libre accès | fr |
| dc.rights | Médecine/Sciences - Inserm - SRMS | fr |
| dc.rights.uri | | |
| dc.source | M/S. Médecine sciences [ISSN papier : 0767-0974 ; ISSN numérique : 1958-5381], Vol. 39, N° 8-9; p. 599-602 | |
| dc.subject.mesh | Humains | fr |
| dc.subject.mesh | Antituberculeux | fr |
| dc.subject.mesh | Produits biologiques | fr |
| dc.subject.mesh | Découverte de médicament | fr |
| dc.subject.mesh | Mycobacterium tuberculosis | fr |
| dc.subject.mesh | usage thérapeutique | fr |
| dc.title | Les séquanamycines, puissants macrolides oraux anti-tuberculeux dérivés d’un produit naturel | fr |
| dc.title.alternative | Discovery of natural product-derived sequanamycins as potent oral anti-tuberculosis agents | en |
| dc.type | Article | |
| dc.contributor.affiliation | Sanofi R&D, Infectious diseases unit , 31036 Toulouse , France | |
| dc.contributor.affiliation | Evotec ID (LYON) SAS , Lyon , France | |
| dc.contributor.affiliation | Sanofi R&D, Integrated drug discovery , Vitry-sur-Seine , France | |
| dc.identifier.doi | 10.1051/medsci/2023091 | |
| dc.identifier.pmid | 37695145 | |
